BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu L, Hong H, Han J, Leng SX, Zhang H, Yan X. Comparison of Survival and Risk Factors of Differentiated Thyroid Cancer in the Geriatric Population. Front Oncol 2020;10:42. [PMID: 32117715 DOI: 10.3389/fonc.2020.00042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Chai J, Zhang R, Zheng W, Zhang G, Jia Q, Tan J, Meng Z, Wang R. Predictive Value of Clinical and Pathological Characteristics for Metastatic Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma: A 16-year Retrospective Study. Front Endocrinol 2022;13:930180. [DOI: 10.3389/fendo.2022.930180] [Reference Citation Analysis]
2 Zhao X, Yang G, Zhang W, Dong Q, Yang Q. Age-related risk for second breast cancer and gynecological malignant neoplasms after differentiated thyroid cancer. Endocrine 2022. [PMID: 35122212 DOI: 10.1007/s12020-022-02999-9] [Reference Citation Analysis]
3 Wang J, Lei M, Xu Z. Aberrant expression of PROS1 correlates with human papillary thyroid cancer progression. PeerJ 2021;9:e11813. [PMID: 34414029 DOI: 10.7717/peerj.11813] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Colombo C, De Leo S, Fugazzola L. Il carcinoma della tiroide nell’anziano: terapia e follow-up. L'Endocrinologo 2021;22:108-110. [DOI: 10.1007/s40619-021-00909-1] [Reference Citation Analysis]
5 Kaliszewski K, Diakowska D, Nowak Ł, Wojtczak B, Rudnicki J. The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice. BMC Cancer 2020;20:1166. [PMID: 33256657 DOI: 10.1186/s12885-020-07636-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]